Eyepoint Pharmaceuticals, Inc. (EYPT) — SC 13G/A Filings
All SC 13G/A filings from Eyepoint Pharmaceuticals, Inc.. Browse 10 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (10)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — May 1, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Adage Capital Amends EyePoint Pharma Stake as of Dec 31, 2023
— Feb 7, 2024
Adage Capital Partners, L.P. has updated its ownership stake in EyePoint Pharmaceuticals, Inc. (EYPT) as of December 31, 2023, filing an amended Schedule 13G/A. -
Franklin Resources Amends EyePoint Pharma Stake (SC 13G/A)
— Feb 6, 2024
Franklin Resources, Inc. filed an amended SC 13G/A on February 6, 2024, indicating a change in their ownership of EyePoint Pharmaceuticals, Inc. common stock as
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX